BlackRock, Inc. 13D and 13G filings for Avanos Medical, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-01-22 2:03 pm Sale |
2023-12-31 | 13G | Avanos Medical, Inc. AVNS |
BLACKROCK INC BLK |
7,461,343 16.100% |
-109,705 (-1.45%) |
Filing |
| 2023-01-26 08:52 am Unchanged |
2022-12-31 | 13G | Avanos Medical, Inc. AVNS |
BLACKROCK INC BLK |
7,571,048 16.300% |
0 (Unchanged) |
Filing |
| 2023-01-20 09:43 am Sale |
2022-12-31 | 13G | Avanos Medical, Inc. AVNS |
BLACKROCK INC BLK |
7,571,048 16.300% |
-42,400 (-0.56%) |
Filing |
| 2022-01-27 5:13 pm Unchanged |
2021-12-31 | 13G | Avanos Medical, Inc. AVNS |
BLACKROCK INC BLK |
7,613,448 15.800% |
0 (Unchanged) |
Filing |
| 2022-01-26 09:16 am Purchase |
2021-12-31 | 13G | Avanos Medical, Inc. AVNS |
BLACKROCK INC BLK |
7,613,448 15.800% |
2,290,107 (+43.02%) |
Filing |
| 2021-01-26 6:52 pm Sale |
2020-12-31 | 13G | Avanos Medical, Inc. AVNS |
BLACKROCK INC BLK |
5,323,341 11.100% |
-228,417 (-4.11%) |
Filing |